17.68
price down icon0.31%   -0.065
 
loading
Roivant Sciences Ltd stock is traded at $17.68, with a volume of 2.78M. It is down -0.31% in the last 24 hours and up +17.59% over the past month. Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
See More
Previous Close:
$17.74
Open:
$17.65
24h Volume:
2.78M
Relative Volume:
0.42
Market Cap:
$12.08B
Revenue:
$125.68M
Net Income/Loss:
$4.81B
P/E Ratio:
3.1283
EPS:
5.65
Net Cash Flow:
$-781.21M
1W Performance:
+7.84%
1M Performance:
+17.59%
6M Performance:
+76.15%
1Y Performance:
+52.19%
1-Day Range:
Value
$17.54
$17.93
1-Week Range:
Value
$16.41
$18.06
52-Week Range:
Value
$8.73
$18.06

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name
Name
Roivant Sciences Ltd
Name
Phone
441-295-5950
Name
Address
7TH FLOOR, 50 BROADWAY, LONDON
Name
Employee
750
Name
Twitter
Name
Next Earnings Date
2025-02-10
Name
Latest SEC Filings
Name
ROIV's Discussions on Twitter

Compare ROIV with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ROIV
Roivant Sciences Ltd
17.70 12.11B 125.68M 4.81B -781.21M 5.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.62 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
476.58 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.21 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.51 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
317.78 34.99B 4.56B -176.77M 225.30M -1.7177

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-02-25 Initiated Citigroup Buy
Jul-10-25 Resumed Goldman Buy
Feb-15-24 Initiated Wolfe Research Outperform
Jan-05-24 Initiated Piper Sandler Overweight
Dec-12-23 Initiated Deutsche Bank Buy
Oct-17-23 Initiated Guggenheim Buy
Jun-08-23 Initiated BofA Securities Neutral
Oct-27-22 Initiated JP Morgan Overweight
May-23-22 Initiated SVB Leerink Outperform
Apr-29-22 Initiated Cantor Fitzgerald Overweight
Dec-15-21 Initiated Goldman Buy
Nov-08-21 Initiated H.C. Wainwright Buy
Oct-28-21 Initiated Citigroup Buy
Oct-26-21 Initiated Cowen Outperform
Oct-26-21 Initiated Jefferies Buy
Oct-26-21 Initiated Truist Buy
View All

Roivant Sciences Ltd Stock (ROIV) Latest News

pulisher
06:04 AM

Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV) - Insider Monkey

06:04 AM
pulisher
05:56 AM

13 Best Growth Stocks Under $25 to Buy Right Now - Insider Monkey

05:56 AM
pulisher
03:37 AM

Risk vs reward if holding onto Roivant Sciences Ltd.Wall Street Watch & Accurate Entry/Exit Alerts - newser.com

03:37 AM
pulisher
03:14 AM

Chart based exit strategy for Roivant Sciences Ltd.Weekly Trading Summary & Weekly Stock Breakout Alerts - newser.com

03:14 AM
pulisher
01:39 AM

Roivant Sciences Ltd. stock prediction for this weekMarket Performance Report & Weekly Stock Performance Updates - newser.com

01:39 AM
pulisher
01:18 AM

Is Roivant Sciences Ltd. (87S) stock undervalued historicallyDip Buying & Long-Term Growth Stock Strategies - newser.com

01:18 AM
pulisher
12:57 PM

Will Roivant Sciences Ltd. (87S) stock outperform benchmarksTrade Signal Summary & Daily Oversold Stock Bounce Ideas - newser.com

12:57 PM
pulisher
Oct 20, 2025

Is Roivant Sciences Ltd. (87S) stock a contrarian opportunityMarket Performance Report & Low Drawdown Investment Ideas - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Is a relief rally coming for Roivant Sciences Ltd. holders2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Roivant Sciences Ltd. (87S) stock cheap by valuation metrics2025 Dividend Review & Real-Time Market Trend Scan - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Combining machine learning predictions for Roivant Sciences Ltd.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What sentiment indicators say about Roivant Sciences Ltd. stockJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

This Red-Hot Biopharma Stock Could Fizzle Out Soon - MSN

Oct 20, 2025
pulisher
Oct 20, 2025

Can you recover from losses in Roivant Sciences Ltd.Earnings Overview Report & Precise Trade Entry Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

(ROIV) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com

Oct 20, 2025
pulisher
Oct 20, 2025

Top chart patterns to watch in Roivant Sciences Ltd.Quarterly Market Summary & Verified Swing Trading Watchlist - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing The 16% Potential Upside - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 20, 2025

Using Ichimoku Cloud for Roivant Sciences Ltd. technicals2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

How sentiment analysis helps forecast Roivant Sciences Ltd.2025 Sector Review & Fast Moving Stock Watchlists - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Will Roivant Sciences Ltd. continue its uptrendJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Will Roivant Sciences Ltd. stock gain from government policiesDay Trade & Daily Technical Stock Forecast Reports - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is Roivant Sciences Ltd. stock in correction or buying zoneMarket Activity Recap & AI Driven Price Predictions - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Roivant Sciences president Venker sells $14.5m in shares By Investing.com - Investing.com Nigeria

Oct 17, 2025
pulisher
Oct 17, 2025

Roivant Sciences president Venker sells $14.5m in shares - Investing.com

Oct 17, 2025
pulisher
Oct 16, 2025

Roivant Sciences Hits New 52-Week High of $17.12, Up 60.59% - Markets Mojo

Oct 16, 2025
pulisher
Oct 15, 2025

Roivant Sciences stock hits all-time high at 16.8 USD By Investing.com - Investing.com South Africa

Oct 15, 2025
pulisher
Oct 15, 2025

Roivant Sciences stock hits all-time high at 16.8 USD - Investing.com India

Oct 15, 2025
pulisher
Oct 15, 2025

Can Roivant Sciences Ltd. stock deliver consistent earnings growth2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Why retail investors pile into Roivant Sciences Ltd. stockQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Roivant Sciences president Venker sells $2m in shares By Investing.com - Investing.com Australia

Oct 15, 2025
pulisher
Oct 14, 2025

Roivant Sciences president Venker sells $2m in shares - Investing.com

Oct 14, 2025
pulisher
Oct 14, 2025

Positive Phase 3 Data and Analyst Support Could Be a Game Changer for Roivant Sciences (ROIV) - Sahm

Oct 14, 2025

Roivant Sciences Ltd Stock (ROIV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Roivant Sciences Ltd Stock (ROIV) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Venker Eric
President & Immunovant CEO
Oct 16 '25
Option Exercise
15.85
318,282
5,044,770
1,823,241
Venker Eric
President & Immunovant CEO
Oct 17 '25
Option Exercise
15.85
118,418
1,876,925
1,623,377
Venker Eric
President & Immunovant CEO
Oct 15 '25
Sale
16.93
414,683
7,020,583
1,504,959
Venker Eric
President & Immunovant CEO
Oct 16 '25
Sale
17.05
318,282
5,426,708
1,504,959
Venker Eric
President & Immunovant CEO
Oct 17 '25
Sale
17.06
118,418
2,020,211
1,504,959
$37.38
price up icon 2.07%
$86.81
price up icon 0.77%
$29.91
price down icon 2.08%
$107.06
price down icon 0.89%
$164.06
price down icon 2.32%
biotechnology ONC
$317.78
price down icon 0.43%
Cap:     |  Volume (24h):